OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease
Ahsas Goyal, Anant Agrawal, Aanchal Verma, et al.
Experimental and Molecular Pathology (2022) Vol. 129, pp. 104846-104846
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Oxidative Stress in Brain Function
Daniela-Marilena Trofin, Dragos-Petrica Sardaru, Dan Trofin, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 297-297
Open Access | Times Cited: 2

Application of curcuminoids in inflammatory, neurodegenerative and aging conditions - Pharmacological potential and bioengineering approaches to improve efficiency
Ricardo Lagoa, Rajan Logesh, Cristiana Violante, et al.
Biotechnology Advances (2025), pp. 108568-108568
Open Access | Times Cited: 2

PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats
Heba A. Farid, Rabab H. Sayed, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1421-1437
Open Access | Times Cited: 24

Neuroprotective effects of cordycepin on MPTP-induced Parkinson's disease mice via suppressing PI3K/AKT/mTOR and MAPK-mediated neuroinflammation
Linhai Wang, Shu Tian, Sisi Ruan, et al.
Free Radical Biology and Medicine (2024) Vol. 216, pp. 60-77
Closed Access | Times Cited: 12

Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes
Alberto Santiago-Balmaseda, Annai Aguirre-Orozco, Irais E. Valenzuela-Arzeta, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 921-921
Open Access | Times Cited: 11

The potential therapeutic role of berberine in treating epilepsy focusing on temporal lobe epilepsy: State of art and ongoing perspective
Bshra A. Alsfouk, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
Brain Research Bulletin (2025) Vol. 221, pp. 111189-111189
Open Access | Times Cited: 1

Advances of phytotherapy in ischemic stroke targeting PI3K/Akt signaling
Tianlong Liu, Wenjun Wang, Xiaolin Li, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5509-5528
Closed Access | Times Cited: 17

Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson's disease in a rat model: Role of PINK-1/PARKIN and PI3K/Akt/CREB/BDNF/TrKB axis
Haneen Y. Khidr, Noha F. Hassan, Sahar S. Abdelrahman, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111207-111207
Closed Access | Times Cited: 16

The spatial landscape of glial pathology and T-cell response in Parkinson’s disease substantia nigra
Kelly Jakubiak, Fahad Paryani, Adithya Kannan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6

The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson’s Disease Animal Models—A Systematic Review
Paul-Ștefan Panaitescu, Vlad Răzniceanu, Ștefania-Maria Mocrei-Rebrean, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 3946-3974
Open Access | Times Cited: 5

Beyond Insulin: The Intriguing Role of GLP-1 in Parkinson's Disease
Aanchal Verma, Ahsas Goyal
European Journal of Pharmacology (2024) Vol. 982, pp. 176936-176936
Closed Access | Times Cited: 5

Exendin‐4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease
Aanchal Verma, Shobhit Chaudhary, Kunal Solanki, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 11

Neurotoxic Effect of Myricitrin in Copper-Induced Oxidative Stress Is Mediated by Increased Intracellular Ca2+ Levels and ROS/p53/p38 Axis
Ignacija Vlašić, Antonio Krstačić-Galić, Anđela Horvat, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 46-46
Open Access

Neuroprotective thiazole sulfonamides against 6-OHDA-induced Parkinsonian model: in vitro biological and in silico pharmacokinetic assessments
Waralee Ruankham, Ratchanok Pingaew, Veda Prachayasittikul, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4281-4295
Open Access

6′-O-caffeoylarbutin of Vaccinium dunalianum alleviated ischemic stroke through the PI3K/AKT/NF-κB pathway
Zhuo-Qi Shi, Xi Wen, Xu Wu, et al.
Phytomedicine (2025) Vol. 139, pp. 156505-156505
Closed Access

Entrectinib can induce nerve cell damage by inhibiting PI3K-AKT and TGF-β signaling pathways
Qi Tang, Jiahong Dong, Feng Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Neurodegenerative diseases and neuroinflammation-induced apoptosis
Shi Huang, Yaxin Lu, Wenjun Fang, et al.
Open Life Sciences (2025) Vol. 20, Iss. 1
Open Access

AAV-mediated GBA1 and GDNF rescue neurological defects in a murine model of neuronopathic Gaucher disease
Yuan Meng, Jiale Zhang, Ruifeng Fan, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 2, pp. 102506-102506
Open Access

Dimeric dipeptide mimetics of neurotrophins as molecular tools and potential neuroprotective drugs
Т. А. Гудашева, P. Yu. Povarnina, В. Л. Дорофеев
(2025) Vol. 2, Iss. 6
Open Access

Page 1 - Next Page

Scroll to top